Healthcare, Pharma & Life Sciences

Messe Düsseldorf’s REHACARE 2026 Adds Community Hub to Center Independent Living Debate

Image
Rehacare

DÜSSELDORF, GERMANY – 22 September 2026 – Messe Düsseldorf will stage REHACARE 2026 from 23 to 26 September in Düsseldorf, placing community creators and people with disabilities at the center of the independent living debate. The trade fair is adding a Community Hub in Hall 7, organized by X Carstens and REHACARE, as a dedicated stage for around 20 creators and influencers across all four trade fair days. The program includes personal stories, talks, roundtables, readings, entertainment and Meet & Greet opportunities, with a Community Day on Saturday, 26 September. For care practitioners, specialist retailers, associations and institutional stakeholders, the move signals a stronger emphasis on user-led perspectives in rehabilitation, prevention, inclusion and nursing care.

Brigham Nurses Set Sept. 24 Strike Vote as MGB Reports $2.39B Profit

Image
Brigham Nurses Set Sept. 24 Strike Vote as MGB Reports $2.39B Profit

Boston – September 21, 2026 -- Nurses and clinicians across Mass General Brigham (MGB) will stage rallies outside the health system's World Medical Innovation Forum on September 22 and 23, escalating a labor dispute that culminates September 24 when 4,000 Brigham and Women's Hospital nurses vote on authorizing an open-ended strike.

Brigham nurses to vote September 24 on open-ended strike authorization

The vote runs from 6 a.m. to 8 p.m. at multiple locations. A "yes" result would empower the Massachusetts Nurses Association (MNA) Bargaining Committee to call a strike, though no date has been set; nurses must give 10 days' legal notice before any walkout begins. The move follows a July 8 strike and a subsequent four-day lockout imposed by MGB, with the hospital system refusing additional negotiating sessions since August.

Georgia Power Donates $10,000 for Color-Accessibility Glasses in State Parks

Image
Georgia Power Donates $10,000 for Color-Accessibility Glasses in State Parks

Atlanta – September 21, 2026 -- Georgia Power is donating $10,000 to launch "Georgia in Color," a fundraising initiative by Friends of Georgia State Parks & Historic Sites to place free EnChroma color-accessibility glasses across all Georgia State Parks.

Georgia Power builds on prior $25,000 commitment to accessibility program

The new donation follows a $25,000 gift the utility made at the end of 2025 to help Friends develop the color-accessibility program. EnChroma glasses use specialized optical filters to enhance color contrast for visitors with red-green color vision deficiency, a condition that can make fall foliage, spring wildflowers and scenic landscapes appear less distinct. Georgia Power has also previously partnered with the Aimee Copeland Foundation to place all-terrain Trackchairs in state parks for visitor use.

EU Approves NewAmsterdam-Menarini's Obicetrapib in Global First

Image
EU Approves NewAmsterdam-Menarini's Obicetrapib in Global First

Florence – September 21, 2026 -- The European Commission has granted marketing authorization for Ubeslo (obicetrapib 10 mg monotherapy) and Evlarco (obicetrapib 10 mg plus ezetimibe 10 mg fixed-dose combination), marking the first global regulatory approval of obicetrapib for NewAmsterdam Pharma (Nasdaq: NAMS) and partner Menarini Group.

EU regulators authorize first CETP inhibitor for elevated LDL-C

The approval covers primary hypercholesterolaemia, including both heterozygous familial hypercholesterolaemia and non-familial or mixed dyslipidaemia. It follows a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use and stands as the first regulatory clearance of obicetrapib anywhere in the world.

Bioness Launches HaloPlex Body Weight Support System for Rehab

Image
Bioness Launches HaloPlex Body Weight Support System for Rehab

Valencia, Calif. – September 21, 2026 -- Bioness Medical, Inc. has commercially launched HaloPlex, an FDA-registered ceiling-mounted body weight support and fall protection system aimed at rehabilitation hospitals, outpatient clinics, and rehab centers treating patients with severe gait and balance impairments.

HaloPlex extends the Vector Gait & Safety System with multidirectional movement support

The system unloads a programmed amount of a patient's body weight while providing continuous postural support and overhead fall protection, allowing patients to practice walking, balance activities, transfers, and functional mobility tasks across a larger therapy space.

Advita Ortho Launches Axis, Backed by 25,000-Patient Shoulder Database

Image
Advita Ortho Launches Axis, Backed by 25,000-Patient Shoulder Database

Gainesville, Fla. – September 21, 2026 -- Advita Ortho has launched Axis, a clinical research platform drawing on more than 20 years of shoulder arthroplasty data covering over 25,000 patients across 45 clinical sites worldwide.

Two decades of data produce 250 peer-reviewed studies

The dataset behind Axis has generated more than 250 peer-reviewed publications and dozens of first-to-market product innovations, according to the company. Chris Roche, Advita Senior Vice President, Extremities, said the initiative distills findings from the company's highest-impact studies into a format designed for practicing surgeons.

Hopper Healthcare Opens Nashville Office to Expand hopperOS Reach

Image
Hopper Healthcare Opens Nashville Office to Expand hopperOS Reach

Nashville, Tenn. – September 21, 2026 -- Hopper Healthcare, developer of the intelligent healthcare operating system hopperOS, is opening a new office in Nashville, Tennessee, a market with more than 900 healthcare companies. The office, located at 501 Corporate Centre Drive, Suite 300, Franklin, TN 37067, will officially open in October 2026.

Hopper Healthcare currently supports more than two million lives across 33 states and 16 countries

The company's platform serves more than 60 hospitals, health systems and ambulatory surgery centers, plus four specialty hospitals. hopperOS is built to connect clinical, operational and financial systems across the care continuum, unifying data and workflows for provider organizations.

Peugeot Invest, Conti Back Mérieux NutriSciences' Certified Group Buy

Image
Peugeot Invest, Conti Back Mérieux NutriSciences' Certified Group Buy

Chicago and Lyon – September 21, 2026 -- Mérieux NutriSciences has secured Peugeot Invest and Continental Grain Company (Conti) as new strategic minority shareholders to help finance its acquisition of Certified Group, a North American testing, inspection and certification (TIC) operator generating approximately $300 million in revenue.

Certified Group deal adds 31 laboratories across North America

The acquisition expands Mérieux NutriSciences' footprint in the world's largest food TIC market, which the company estimates at more than $2.5 billion for outsourced services. Certified Group's network brings capabilities in animal protein, dairy and packaged foods, alongside adjacent sectors including cosmetics, health supplements, over-the-counter drugs and reduced-harm nicotine products.

FINN Partners Releases Brain Health eBook Amid UNGA81 Summits

Image
FINN Partners Releases Brain Health eBook Amid UNGA81 Summits

New York – – September 21, 2026 -- FINN Partners has released a new eBook, The Next Frontier in Brain Health, timed to World Alzheimer's Day and the opening of the United Nations General Assembly in New York. The collection arrives as the World Health Organization reports nearly 10 million new dementia cases develop worldwide each year, with delayed diagnoses and fragmented patient journeys leaving families without clear direction.

Collection targets the gap between scientific advances and patient care

The eBook argues that complex scientific information often fails to reach patients, caregivers and policymakers in usable form. Richard Hatzfeld, Senior Partner and global lead for FINN's Global Health Practice brain health initiatives, edited the collection and said it brings together FINN colleagues to help clients explain the science, address barriers to care and embed brain health into workplace and public policy decisions.

Nabsys Pairs CRISPR/Cas9 With Electronic Genome Mapping in New Study

Image
Nabsys Pairs CRISPR/Cas9 With Electronic Genome Mapping in New Study

Providence, R.I. – September 21, 2026 -- Nabsys 2.0, LLC has published the first study combining CRISPR/Cas9 with its proprietary Electronic Genome Mapping (EGM) technology, demonstrating a method to both evaluate CRISPR/Cas9 activity and direct EGM to target specific genomic regions rather than only genome-wide analysis.

The preprint, titled 'CRISPR/Cas9 Optimization Using Electronic Genome Mapping: Potential Role for Studying Human Genetic Disease,' was led by John F. Thompson, Ph.D., Principal Application Scientist at Nabsys, and posted on bioRxiv.